BE870314A - Emploi de la combinaison d'acide clofibrinique ou de clofibrate avec la cinnarizine pour le traitement de l'hypertension - Google Patents

Emploi de la combinaison d'acide clofibrinique ou de clofibrate avec la cinnarizine pour le traitement de l'hypertension

Info

Publication number
BE870314A
BE870314A BE190342A BE190342A BE870314A BE 870314 A BE870314 A BE 870314A BE 190342 A BE190342 A BE 190342A BE 190342 A BE190342 A BE 190342A BE 870314 A BE870314 A BE 870314A
Authority
BE
Belgium
Prior art keywords
cinnarizine
clofibrate
hypertension
treatment
combination
Prior art date
Application number
BE190342A
Other languages
English (en)
Inventor
G Metz
M Specker
Original Assignee
Merckle Kg Chem Pharm L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US05/936,513 priority Critical patent/US4156003A/en
Application filed by Merckle Kg Chem Pharm L filed Critical Merckle Kg Chem Pharm L
Priority to BE190342A priority patent/BE870314A/fr
Publication of BE870314A publication Critical patent/BE870314A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE190342A 1978-08-24 1978-09-08 Emploi de la combinaison d'acide clofibrinique ou de clofibrate avec la cinnarizine pour le traitement de l'hypertension BE870314A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US05/936,513 US4156003A (en) 1978-08-24 1978-08-24 Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine
BE190342A BE870314A (fr) 1978-08-24 1978-09-08 Emploi de la combinaison d'acide clofibrinique ou de clofibrate avec la cinnarizine pour le traitement de l'hypertension

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/936,513 US4156003A (en) 1978-08-24 1978-08-24 Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine
BE190342A BE870314A (fr) 1978-08-24 1978-09-08 Emploi de la combinaison d'acide clofibrinique ou de clofibrate avec la cinnarizine pour le traitement de l'hypertension

Publications (1)

Publication Number Publication Date
BE870314A true BE870314A (fr) 1979-01-02

Family

ID=25650980

Family Applications (1)

Application Number Title Priority Date Filing Date
BE190342A BE870314A (fr) 1978-08-24 1978-09-08 Emploi de la combinaison d'acide clofibrinique ou de clofibrate avec la cinnarizine pour le traitement de l'hypertension

Country Status (2)

Country Link
US (1) US4156003A (fr)
BE (1) BE870314A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060052457A1 (en) * 2002-03-11 2006-03-09 Peter Zahradka Use of ppar alpha agonists for the treatment of vascular and renal diseases
US7232828B2 (en) * 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882271A (en) * 1959-04-14 Xcixcxh
DE2502678C3 (de) * 1975-01-23 1981-05-14 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Arzneimittel zur Behandlung primärer und sekundärer Hyperlipoproteinämien

Also Published As

Publication number Publication date
US4156003A (en) 1979-05-22

Similar Documents

Publication Publication Date Title
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
OA08617A (fr) Inhibiteurs de métalloendopeptidase neutre dans le traitement de l'hypertention.
BE859817A (fr) Compositions notamment utiles pour le traitement de l'acne
RO69941A (fr) Procede pour la preparation des derives de la pyroline de l'acide azetidine-2 carboxylique ou de l'acide pipecolique
FR2522508B1 (fr) Ensemble pour l'introduction de catheters
BE830668A (fr) Agents emulsionnants et epaississants de l'eau
PT69628B (pt) Procede pour la preparation de compositions au effet anorexigenique en mammiferes contenant naltrexonne ou un sel delui
FR2275436A1 (fr) Procede pour la preparation de l'acide acrylique ou de l'acide methacrylique
FR2533929B1 (fr) Ester methylique de l'acide 25, 26, 27 -trinor-1a, 2b-epoxy-cholesta-4,6-diene-3-one-24-oique
OA06289A (fr) La préparation d'agents antiviraux.
BE854582A (fr) Emploi d'acides propanediphosphoniques-1,3 et -phosphoniques-1,3 substitues en position 1 pour conditionner l'eau
BE857186A (fr) Lit pour s'asseoir ou se coucher
IT1194380B (it) Procedimento per migliorare le solidita' ad umido delle tinture su substarti tessili
RO75590A (fr) Procede pour la preparation d'acrylate ou methacrylate de methyle
IT1123508B (it) Procedimento per l'innesto di particelle di gomma dienica in emulsione
BE873092A (fr) Composition pour le traitement de l'hypertension
BE862274A (fr) Acides carboxyphosphoriques utilisables pour le traitement d'eaux
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE870314A (fr) Emploi de la combinaison d'acide clofibrinique ou de clofibrate avec la cinnarizine pour le traitement de l'hypertension
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE858692A (fr) Composition pour le traitement de l'acne
FR2536995B1 (fr) Composition pour le traitement de l'arthrite
BE763579A (fr) Nouvel ether de lysolecithine et utilisation des ethers de lysolecithines comme agents pour l'accroissement de la resistance naturelle de l'organisme
FR2297828A1 (fr) Procede pour la fabrication d'acide acrylique ou d'acide methacrylique
FR2526792B1 (fr) Derives d'aletheine utiles pour le traitement des lesions hepatiques

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: LUDWIG MERCKLE K.G. CHEM. PHARM. FABRIK

Effective date: 19920930